Client Satisfaction
& Testimonials
Client satisfaction
Client satisfaction is a key measure of our success. We continuously collect feedback through client satisfaction surveys to evaluate the quality of our scientific expertise, project management, communication, and overall collaboration.
The results from our 2024–2026 surveys reflect our commitment to delivering high-quality, reliable, and responsive drug discovery services.
Client testimonials
Alongside these metrics, we are proud to share testimonials from our clients, whose experiences highlight the value of partnering with Axxam across a wide range of discovery programs.
“It was a pleasure to work with Axxam to develop a highly sensitive and specific potency assay for our candidate product. The assay has been validated across all key parameters and is robust and reproducible, thereby meeting key EMA ICH guidelines. This success allowed us to comply with regulatory requirements and will enable us to advance from early phase development towards pivotal studies.”
Scott Jeffers
Chief Technical Officer
GenSight Biologics
“By supporting a biotech start-up, my experience with Axxam’s compound management services has been excellent. Throughout the HTS screening at Axxam and subsequent studies across multiple research labs and CROs, compound acquisition and delivery were consistently timely and free of shipping errors. This reliability, also in the HTS, was driven by highly responsive communication, broad availability, and a proactive approach to addressing questions—ensuring both timelines and quality were maintained throughout.”
Rene Dumay-Roscher
VP Pharma
DIAMANTE healthcare consulting
“Selonterra entered into a drug discovery collaboration with Axxam in 2020 and is working with Axxam ever since. Axxam is providing essential and high-quality support for our discovery and profiling of small molecules to treat neurodegenerative disorders, including Alzheimer’s disease. We particularly appreciate the accessibility of their scientists and support by their leadership to rapidly complete tasks and help advancing our projects.”
Roman Urfer, PhD
Founder and Chief Executive Officer
Selonterra, Inc.